HTL Biotechnology inaugurates a new production line dedicated to sterile Hyaluronic Acid
As part of National Biomanufacturing Day 2025, HTL Biotechnology inaugurates a new production line dedicated to Hyaluronic Acid.
Oligo HA
Building upon our premium quality Hyaluronic Acid
HA oligomers and ultra-low molecular weight hyaluronic acid are increasingly popular to modulate rheological or biological effects.
Building upon our 30 years of experience manufacturing pharmaceutical hyaluronic acid, we are expanding our range to support medical innovations worldwide.
Features
Small molecule with high potential
- Ultra-low molecular weight
- Complete range of hyaluronan oligomer from 5-100 kDa
- Non-animal origin
Advantages
- Support from research to pre-clinical stages of drug delivery solutions, microneedles manufacturing, and cell culture
- Reduces solution viscosity at standard concentration compared to higher molecular weight HA
- For native use or chemical modifications
Applications
MICRONEEDLES
DRUG DELIVERY
AESTHETICS
Discover our
other solutions
Innovation Portfolio
Recombinant Human Collagen III
Discover HTL Biotechnology’s new recombinant human collagen with unique properties.
Product Portfolio
Hyaluronic Acid (Sodium Hyaluronate)
Premium Pharma-grade Hyaluronic Acid (Sodium Hyaluronate)
Product Portfolio
Polynucleotides (PDRN - PN)
Premium Pharma-grade Polynucleotides
Product Portfolio
Sodium DNA
Cosmetic grade DNA
Innovation Portfolio
Heparosan
Building on the success of Hyaluronic Acid, HTL Biotechnology now wishes to bring new opportunities with Heparosan.